Ahmed El-morsy

887 total citations
29 papers, 753 citations indexed

About

Ahmed El-morsy is a scholar working on Organic Chemistry, Molecular Biology and Aquatic Science. According to data from OpenAlex, Ahmed El-morsy has authored 29 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 11 papers in Molecular Biology and 3 papers in Aquatic Science. Recurrent topics in Ahmed El-morsy's work include Synthesis and biological activity (16 papers), Synthesis and Biological Evaluation (10 papers) and Quinazolinone synthesis and applications (8 papers). Ahmed El-morsy is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Biological Evaluation (10 papers) and Quinazolinone synthesis and applications (8 papers). Ahmed El-morsy collaborates with scholars based in Egypt, Iraq and Saudi Arabia. Ahmed El-morsy's co-authors include Ashraf H. Bayoumi, Kamal M. El‐Gamal, Mohamed Alswah, Farag F. Sherbiny, Ibrahim H. Eissa, Hamada S. Abulkhair, Adel Ghiaty, Ahmed A. Abdel Gaber, Khaled El‐Adl and Ahmed B. M. Mehany and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Ahmed El-morsy

28 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed El-morsy Egypt 13 578 304 88 65 58 29 753
Marwa F. Harras Egypt 17 582 1.0× 213 0.7× 132 1.5× 76 1.2× 52 0.9× 45 753
Elshimaa M. N. Abdelhafez Egypt 16 452 0.8× 255 0.8× 68 0.8× 68 1.0× 44 0.8× 39 629
Heba S. A. Elzahabi Egypt 17 761 1.3× 252 0.8× 80 0.9× 97 1.5× 58 1.0× 35 912
Rajesh Kakadiya Taiwan 16 506 0.9× 335 1.1× 86 1.0× 26 0.4× 37 0.6× 35 695
Eman M. H. Abbas Egypt 16 605 1.0× 161 0.5× 37 0.4× 48 0.7× 27 0.5× 45 683
Ahmed B. M. Mehany Egypt 12 418 0.7× 206 0.7× 66 0.8× 56 0.9× 54 0.9× 24 531
Khaled O. Mohamed Egypt 16 409 0.7× 184 0.6× 42 0.5× 40 0.6× 50 0.9× 36 517
Agnieszka Gornowicz Poland 14 246 0.4× 258 0.8× 117 1.3× 22 0.3× 49 0.8× 38 643
Heba A. Hassan Egypt 14 387 0.7× 261 0.9× 94 1.1× 50 0.8× 22 0.4× 31 595
Essam Eldin A. Osman Egypt 12 202 0.3× 162 0.5× 74 0.8× 51 0.8× 16 0.3× 19 403

Countries citing papers authored by Ahmed El-morsy

Since Specialization
Citations

This map shows the geographic impact of Ahmed El-morsy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed El-morsy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed El-morsy more than expected).

Fields of papers citing papers by Ahmed El-morsy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed El-morsy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed El-morsy. The network helps show where Ahmed El-morsy may publish in the future.

Co-authorship network of co-authors of Ahmed El-morsy

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed El-morsy. A scholar is included among the top collaborators of Ahmed El-morsy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed El-morsy. Ahmed El-morsy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El-Haddad, Alaadin E., Ahmed El-morsy, Hussein S. Mohamed, et al.. (2025). Kinase and aldose reductase inhibitors from Chenopodium album : UPLC/T-TOF-MS/MS, in-vitro , and in- silico studies. Analytical Chemistry Letters. 15(1). 1–17.
2.
El‐Adl, Khaled, et al.. (2025). A two-decade overview of oxadiazole derivatives as promising anticancer agents. RSC Advances. 15(39). 32778–32795. 4 indexed citations
3.
Mohamed, Hussein S., et al.. (2025). Antibacterial and anti-tumor properties of marine posidonoia oceanica leaf extracts. Journal of Herbs Spices & Medicinal Plants. 31(3). 268–290. 2 indexed citations
4.
El-morsy, Ahmed, M. Al-Amri, Aishah M. Alsibaee, et al.. (2025). Synthesis and characterization of sodium alginate/poly(N-vinylpyrrolidone) nano-carrier loaded with rebaudioside A and/or stevioside for anticancer drug delivery. International Journal of Biological Macromolecules. 316(Pt 2). 144778–144778. 1 indexed citations
5.
6.
El‐Hddad, Sanadelaslam S. A., et al.. (2024). Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation. RSC Advances. 14(19). 13237–13250. 5 indexed citations
7.
El‐Adl, Khaled, et al.. (2024). Radiation synthesis and characterization of pH-Responsive sodium Alginate/Poly(acrylic acid) nanogel loaded with ferulic acid for anticancer drug delivery. Materials Chemistry and Physics. 322. 129564–129564. 12 indexed citations
8.
El‐Adl, Khaled, et al.. (2024). Radiation-induced nanogel engineering based on pectin for pH-responsive rutin delivery for cancer treatment. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(5). 5249–5271. 6 indexed citations
9.
Awaji, Aeshah A., Mohamed Alswah, Mohamed M. Elsebaei, et al.. (2024). N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity. Bioorganic Chemistry. 145. 107228–107228. 12 indexed citations
10.
Alswah, Mohamed, Mohamed M. Elsebaei, Ashraf H. Bayoumi, et al.. (2023). Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies. International Journal of Molecular Sciences. 24(19). 15026–15026. 4 indexed citations
11.
12.
Elwan, Alaa, Helmy Sakr, Abdel‐Ghany A. El‐Helby, et al.. (2022). Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1556–1567. 11 indexed citations
13.
14.
Abulkhair, Hamada S., Adel Ghiaty, Ahmed El-morsy, et al.. (2021). In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors. Archiv der Pharmazie. 354(5). e2000449–e2000449. 37 indexed citations
15.
Bayoumi, Ashraf H., Farag F. Sherbiny, Ahmed El-morsy, et al.. (2020). Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists. Molecular Diversity. 25(1). 291–306. 37 indexed citations
16.
Omar, Abdelsattar M., Mohamed Alswah, Hany E. A. Ahmed, et al.. (2020). Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B. Bioorganic Chemistry. 96. 103656–103656. 29 indexed citations
17.
Gaber, Ahmed A. Abdel, Ashraf H. Bayoumi, Ahmed El-morsy, et al.. (2018). Design, synthesis and anticancer evaluation of 1H-pyrazolo[3,4-d]pyrimidine derivatives as potent EGFRWT and EGFRT790M inhibitors and apoptosis inducers. Bioorganic Chemistry. 80. 375–395. 122 indexed citations
18.
El-morsy, Ahmed, Mohamed Elsayed, & Hamada S. Abulkhair. (2017). Synthesis, Characterization and <i>In Vitro</i> Antitumor Evaluation of New Pyrazolo[3,4-d]Pyrimidine Derivatives. 7(1). 1–17. 12 indexed citations
19.
El-morsy, Ahmed, et al.. (2016). The effect of water aquaria change on nutrient utilization and microbial activity of Nile tilapia Oreochromis niloticus. International Journal of Fisheries and Aquatic Studies. 4(4). 196–205. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marwa F. Harras Breakdown of academic impact, for papers by Elshimaa M. N. Abdelhafez Breakdown of academic impact, for papers by Heba S. A. Elzahabi Breakdown of academic impact, for papers by Rajesh Kakadiya Breakdown of academic impact, for papers by Eman M. H. Abbas Breakdown of academic impact, for papers by Ahmed B. M. Mehany Breakdown of academic impact, for papers by Khaled O. Mohamed Breakdown of academic impact, for papers by Agnieszka Gornowicz Breakdown of academic impact, for papers by Heba A. Hassan Breakdown of academic impact, for papers by Essam Eldin A. Osman
Rankless by CCL
2026